MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-05-2023
Heska Corporation PEG Ratio 2011-2026 | HSKA
Annual PEG Ratio Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.41 | -87.2 | 5.02 | 4.15 | -2.83 | -6.62 | 0.552 | 0.567 | -0.147 | 0.217 | -0.848 | 0.00157 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.02 | -87.2 | -6.98 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M |  Germany |
 |
DexCom
DXCM
|
1.12 | $ 63.66 | -3.68 % | $ 24.8 B |  USA |
 |
Fulgent Genetics
FLGT
|
-0.00389 | $ 15.54 | -5.13 % | $ 470 M | USA |
|
Biodesix
BDSX
|
1.09 | $ 13.97 | -4.32 % | $ 1.81 B | USA |
 |
DarioHealth Corp.
DRIO
|
-0.00446 | $ 8.45 | - | $ 33.7 M |  Israel |
 |
Enzo Biochem
ENZ
|
-0 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.798 | - | - | $ 19.8 B | USA |
|
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M |  Canada |
 |
ICON Public Limited Company
ICLR
|
1.16 | $ 103.93 | 0.82 % | $ 8.57 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
-0.0368 | - | - | $ 9.42 M | Israel |
 |
IQVIA Holdings
IQV
|
1.57 | $ 165.44 | -2.34 % | $ 28.4 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M |  Britain |
 |
IDEXX Laboratories
IDXX
|
3.06 | $ 567.77 | -0.96 % | $ 45.7 B | USA |
 |
Illumina
ILMN
|
2.16 | $ 119.22 | -4.16 % | $ 19 B | USA |
 |
Lantheus Holdings
LNTH
|
-0.338 | $ 75.32 | -1.36 % | $ 5.08 B | USA |
 |
Medpace Holdings
MEDP
|
0.906 | $ 457.07 | -2.04 % | $ 13.2 B | USA |
 |
DermTech
DMTK
|
-0.847 | - | -11.32 % | $ 2.94 M | USA |
 |
Aspira Women's Health
AWH
|
-0.0104 | - | -6.19 % | $ 10.5 M | USA |
 |
Mettler-Toledo International
MTD
|
4.59 | $ 1 238.68 | -2.47 % | $ 25.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
-0.00983 | $ 4.42 | -4.44 % | $ 409 M | USA |
 |
Co-Diagnostics
CODX
|
0.00787 | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Accelerate Diagnostics
AXDX
|
0.114 | - | -61.36 % | $ 2.46 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.0591 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-0.00417 | - | 0.12 % | $ 80.1 M | China |
 |
Natera
NTRA
|
-0.401 | $ 191.42 | -2.41 % | $ 18.8 B | USA |
 |
National Research Corporation
NRC
|
-7.14 | $ 17.08 | -1.62 % | $ 382 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-0.00137 | - | -20.0 % | $ 1.06 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | USA |
 |
OPKO Health
OPK
|
-0.902 | $ 1.13 | -3.85 % | $ 784 M | USA |
 |
Charles River Laboratories International
CRL
|
9.49 | $ 157.42 | -4.67 % | $ 7.8 B | USA |
 |
Organovo Holdings
ONVO
|
0.0583 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
0.00227 | - | -16.95 % | $ 1.54 M | USA |
 |
Pacific Biosciences of California
PACB
|
-0.0332 | $ 1.27 | -5.93 % | $ 381 M | USA |
 |
Biocept
BIOC
|
-0.000363 | - | -13.05 % | $ 7.29 M | USA |
 |
ENDRA Life Sciences
NDRA
|
-0.000022 | $ 4.8 | 4.58 % | $ 2.58 M | USA |
 |
Personalis
PSNL
|
-2.42 | $ 6.66 | -9.02 % | $ 395 M | USA |
 |
PerkinElmer
PKI
|
-10.2 | - | -0.91 % | $ 14.7 B | USA |
 |
Invitae Corporation
NVTA
|
0.225 | - | - | $ 21.2 M | USA |
 |
Interpace Biosciences
IDXG
|
-0.00557 | $ 1.73 | 2.37 % | $ 7.59 M | USA |
 |
RadNet
RDNT
|
-52.4 | $ 57.34 | -3.49 % | $ 4.31 B | USA |
 |
Sotera Health Company
SHC
|
1.66 | $ 13.26 | -2.07 % | $ 3.77 B | USA |
 |
Motus GI Holdings
MOTS
|
-0.069 | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
3.43 | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
0.383 | $ 30.09 | -5.48 % | $ 1.53 B | USA |
 |
Thermo Fisher Scientific
TMO
|
9.76 | $ 478.97 | -2.06 % | $ 181 B | USA |
 |
Trinity Biotech plc
TRIB
|
-0.637 | $ 0.62 | 1.06 % | $ 61.9 M | Irlanda |